Addressing unmet needs in understanding asthma mechanisms

Michael Edwards; Sejal Saglani; Jurgen Schwarze; Chrysanthi Skevaki; Jaclyn Smith; Ben Ainsworth; Mark Almond; Evangelos Andreakos; Maria Belvisi; Kian Fan Chung; William Cookson; Paul Cullinan; Catherine Hawrylowicz; Marek Lommatzsch; David Jackson; Rene Lutter; Benjamin Marsland; Miriam Moffat; Mike Thomas; J. Christian Virchow; Georgina Xanthou; Jessica Edwards; Samantha Walker; Sebastian L. Johnston; EARIP WP2 Working Group

doi:10.1183/13993003.02448-2016

Addressing unmet needs in understanding asthma mechanisms

Michael Edwards, Sejal Saglani, Jurgen Schwarze, Chrysanthi Skevaki, Jaclyn Smith, Ben Ainsworth, Mark Almond, Evangelos Andreakos, Maria Belvisi, Kian Fan Chung, William Cookson, Paul Cullinan, Catherine Hawrylowicz, Marek Lommatzsch, David Jackson, Rene Lutter, Benjamin Marsland, Miriam Moffat, Mike Thomas, J. Christian VirchowGeorgina Xanthou, Jessica Edwards, Samantha Walker, Sebastian L. Johnston, EARIP WP2 Working Group

Research output: Contribution to journal › Article › peer-review

50 Citations (SciVal)

76 Downloads (Pure)

Abstract

Asthma is a heterogeneous, complex disease with clinical phenotypes that incorporate persistent symptoms and acute exacerbations. It affects many millions of Europeans throughout their education and working lives and puts a heavy cost on European productivity. There is a wide spectrum of disease severity and control. Therapeutic advances have been slow despite greater understanding of basic mechanisms and the lack of satisfactory preventative and disease modifying management for asthma constitutes a significant unmet clinical need. Preventing, treating and ultimately curing asthma requires co-ordinated research and innovation across Europe. The European Asthma Research and Innovation Partnership (EARIP) is an FP7-funded programme which has taken a co-ordinated and integrated approach to analysing the future of asthma research and development. This report aims to identify the mechanistic areas in which investment is required to bring about significant improvements in asthma outcomes.

Original language	English
Article number	1602448
Pages (from-to)	1-43
Number of pages	43
Journal	European Respiratory Journal
Volume	49
Issue number	5
Early online date	1 May 2017
DOIs	https://doi.org/10.1183/13993003.02448-2016
Publication status	Published - 1 May 2017

Bibliographical note

M1 - 1602448

Access to Document

10.1183/13993003.02448-2016

Johnston_et_al._ERJ_2017_Accepted_Manuscript.PDFAccepted author manuscript, 3.43 MB

https://eprints.soton.ac.uk/408600/

Cite this

Edwards, M., Saglani, S., Schwarze, J., Skevaki, C., Smith, J., Ainsworth, B., Almond, M., Andreakos, E., Belvisi, M., Chung, K. F., Cookson, W., Cullinan, P., Hawrylowicz, C., Lommatzsch, M., Jackson, D., Lutter, R., Marsland, B., Moffat, M., Thomas, M., ... Group, EARIP. WP. W. (2017). Addressing unmet needs in understanding asthma mechanisms. European Respiratory Journal, 49(5), 1-43. Article 1602448. https://doi.org/10.1183/13993003.02448-2016

Edwards, M, Saglani, S, Schwarze, J, Skevaki, C, Smith, J, Ainsworth, B, Almond, M, Andreakos, E, Belvisi, M, Chung, KF, Cookson, W, Cullinan, P, Hawrylowicz, C, Lommatzsch, M, Jackson, D, Lutter, R, Marsland, B, Moffat, M, Thomas, M, Virchow, JC, Xanthou, G, Edwards, J, Walker, S, Johnston, SL & Group, EARIPWPW 2017, 'Addressing unmet needs in understanding asthma mechanisms', European Respiratory Journal, vol. 49, no. 5, 1602448, pp. 1-43. https://doi.org/10.1183/13993003.02448-2016

@article{832128c081854ea7a467df1f2416fcb9,

title = "Addressing unmet needs in understanding asthma mechanisms",

abstract = "Asthma is a heterogeneous, complex disease with clinical phenotypes that incorporate persistent symptoms and acute exacerbations. It affects many millions of Europeans throughout their education and working lives and puts a heavy cost on European productivity. There is a wide spectrum of disease severity and control. Therapeutic advances have been slow despite greater understanding of basic mechanisms and the lack of satisfactory preventative and disease modifying management for asthma constitutes a significant unmet clinical need. Preventing, treating and ultimately curing asthma requires co-ordinated research and innovation across Europe. The European Asthma Research and Innovation Partnership (EARIP) is an FP7-funded programme which has taken a co-ordinated and integrated approach to analysing the future of asthma research and development. This report aims to identify the mechanistic areas in which investment is required to bring about significant improvements in asthma outcomes.",

author = "Michael Edwards and Sejal Saglani and Jurgen Schwarze and Chrysanthi Skevaki and Jaclyn Smith and Ben Ainsworth and Mark Almond and Evangelos Andreakos and Maria Belvisi and Chung, {Kian Fan} and William Cookson and Paul Cullinan and Catherine Hawrylowicz and Marek Lommatzsch and David Jackson and Rene Lutter and Benjamin Marsland and Miriam Moffat and Mike Thomas and Virchow, {J. Christian} and Georgina Xanthou and Jessica Edwards and Samantha Walker and Johnston, {Sebastian L.} and Group, {EARIP WP2 Working}",

note = "M1 - 1602448",

year = "2017",

month = may,

day = "1",

doi = "10.1183/13993003.02448-2016",

language = "English",

volume = "49",

pages = "1--43",

journal = "European Respiratory Journal",

issn = "0903-1936",

publisher = "European Respiratory Society",

number = "5",

}

TY - JOUR

T1 - Addressing unmet needs in understanding asthma mechanisms

AU - Edwards, Michael

AU - Saglani, Sejal

AU - Schwarze, Jurgen

AU - Skevaki, Chrysanthi

AU - Smith, Jaclyn

AU - Ainsworth, Ben

AU - Almond, Mark

AU - Andreakos, Evangelos

AU - Belvisi, Maria

AU - Chung, Kian Fan

AU - Cookson, William

AU - Cullinan, Paul

AU - Hawrylowicz, Catherine

AU - Lommatzsch, Marek

AU - Jackson, David

AU - Lutter, Rene

AU - Marsland, Benjamin

AU - Moffat, Miriam

AU - Thomas, Mike

AU - Virchow, J. Christian

AU - Xanthou, Georgina

AU - Edwards, Jessica

AU - Walker, Samantha

AU - Johnston, Sebastian L.

AU - Group, EARIP WP2 Working

N1 - M1 - 1602448

PY - 2017/5/1

Y1 - 2017/5/1

N2 - Asthma is a heterogeneous, complex disease with clinical phenotypes that incorporate persistent symptoms and acute exacerbations. It affects many millions of Europeans throughout their education and working lives and puts a heavy cost on European productivity. There is a wide spectrum of disease severity and control. Therapeutic advances have been slow despite greater understanding of basic mechanisms and the lack of satisfactory preventative and disease modifying management for asthma constitutes a significant unmet clinical need. Preventing, treating and ultimately curing asthma requires co-ordinated research and innovation across Europe. The European Asthma Research and Innovation Partnership (EARIP) is an FP7-funded programme which has taken a co-ordinated and integrated approach to analysing the future of asthma research and development. This report aims to identify the mechanistic areas in which investment is required to bring about significant improvements in asthma outcomes.

AB - Asthma is a heterogeneous, complex disease with clinical phenotypes that incorporate persistent symptoms and acute exacerbations. It affects many millions of Europeans throughout their education and working lives and puts a heavy cost on European productivity. There is a wide spectrum of disease severity and control. Therapeutic advances have been slow despite greater understanding of basic mechanisms and the lack of satisfactory preventative and disease modifying management for asthma constitutes a significant unmet clinical need. Preventing, treating and ultimately curing asthma requires co-ordinated research and innovation across Europe. The European Asthma Research and Innovation Partnership (EARIP) is an FP7-funded programme which has taken a co-ordinated and integrated approach to analysing the future of asthma research and development. This report aims to identify the mechanistic areas in which investment is required to bring about significant improvements in asthma outcomes.

U2 - 10.1183/13993003.02448-2016

DO - 10.1183/13993003.02448-2016

M3 - Article

SN - 0903-1936

VL - 49

SP - 1

EP - 43

JO - European Respiratory Journal

JF - European Respiratory Journal

IS - 5

M1 - 1602448

ER -

Addressing unmet needs in understanding asthma mechanisms

Abstract

Bibliographical note

Access to Document

Fingerprint

Cite this